Relay Therapeutics, Inc. (RLAY): Total Assets
$621.33M
As of 2025-12-31
$967.46M
As of 2026-06-30
-17.3%
3-year compound annual growth
-4.9%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $621.33M | -28.7% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $871.30M | +3.2% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $843.98M | -23.3% | 2025-02-26, Balance as of period end |
| 2022-12-31 | $1.10B | +9.1% | 2024-02-22, Balance as of period end |
| 2021-12-31 | $1.01B | +26.1% | 2023-02-23, Balance as of period end |
| 2020-12-31 | $799.83M | +103.5% | 2022-02-24, Balance as of period end |
| 2019-12-31 | $393.07M | n/a | 2021-03-25, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Relay Therapeutics, Inc. (RLAY) | 2025-12-31 | $621.33M | -28.7% |
| Lineage Cell Therapeutics, Inc. (LCTX) | 2025-12-31 | $112.58M | -0.6% |
| Pelthos Therapeutics Inc. (PTHS) | 2025-12-31 | $130.40M | n/m |
| LENZ Therapeutics, Inc. (LENZ) | 2025-12-31 | $305.88M | +42.1% |
| Alector, Inc. (ALEC) | 2025-12-31 | $293.24M | -37.4% |
| Caribou Biosciences, Inc. (CRBU) | 2025-12-31 | $175.37M | -44.0% |
| TScan Therapeutics, Inc. (TCRX) | 2025-12-31 | $228.79M | -38.4% |
| Alpha Cognition Inc. (ACOG) | 2025-12-31 | $79.73M | +57.1% |
| Taysha Gene Therapies, Inc. (TSHA) | 2025-12-31 | $343.32M | +114.1% |
Compare RLAY, LCTX, PTHS, LENZ side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗